NasdaqGS - Delayed Quote USD
Allogene Therapeutics, Inc. (ALLO)
2.0000 -0.0200 (-0.99%)
At close: August 31 at 4:00:00 PM EDT
Trade ALLO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for ALLO
What's happening with ALLO?
Powered by Yahoo ScoutAllogene Therapeutics (ALLO) has shown significant progress in its clinical trials and financial performance, highlighted by a 49.6% year-to-date stock gain. The company reported a narrower Q2 loss and received regulatory designations that could enhance its market position.
Powered by Yahoo Scout
- Previous Close
2.0200 - Open
2.0050 - Bid 1.9800 x 200
- Ask 2.0000 x 100
- Day's Range
1.9550 - 2.0200 - 52 Week Range
1.0400 - 4.4600 - Volume
4,371,373 - Avg. Volume
7,646,164 - Market Cap (intraday)
690.982M - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6600 - Earnings Date Nov 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
9.00
Recent News
View More
Performance Overview
Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ALLO
45.99%
S&P 500 (^GSPC)
12.28%
1-Year Return
ALLO
76.99%
S&P 500 (^GSPC)
18.98%
3-Year Return
ALLO
48.59%
S&P 500 (^GSPC)
70.51%
5-Year Return
ALLO
91.61%
S&P 500 (^GSPC)
69.95%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 8/27/2026
Market Cap
723.80M
Enterprise Value
461.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
114.90
Price/Book (mrq)
1.66
Enterprise Value/Revenue
99.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-22.08%
Return on Equity (ttm)
-42.39%
Revenue (ttm)
4.64M
Net Income Avi to Common (ttm)
-165.49M
Diluted EPS (ttm)
-0.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
332.6M
Total Debt/Equity (mrq)
18.11%
Levered Free Cash Flow (ttm)
-63.46M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.